[go: up one dir, main page]

GB201309085D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201309085D0
GB201309085D0 GBGB1309085.7A GB201309085A GB201309085D0 GB 201309085 D0 GB201309085 D0 GB 201309085D0 GB 201309085 A GB201309085 A GB 201309085A GB 201309085 D0 GB201309085 D0 GB 201309085D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1309085.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharma Ltd
Original Assignee
Redx Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharma Ltd filed Critical Redx Pharma Ltd
Priority to GBGB1309085.7A priority Critical patent/GB201309085D0/en
Publication of GB201309085D0 publication Critical patent/GB201309085D0/en
Priority to PCT/GB2014/051542 priority patent/WO2014188173A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1309085.7A 2013-05-20 2013-05-20 Compounds Ceased GB201309085D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1309085.7A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds
PCT/GB2014/051542 WO2014188173A1 (en) 2013-05-20 2014-05-20 Pyrazolopyrimidine derivatives useful as inhibitors of bruton's tyrosine kinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1309085.7A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Publications (1)

Publication Number Publication Date
GB201309085D0 true GB201309085D0 (en) 2013-07-03

Family

ID=48747060

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1309085.7A Ceased GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Country Status (2)

Country Link
GB (1) GB201309085D0 (en)
WO (1) WO2014188173A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410430D0 (en) * 2014-06-11 2014-07-23 Redx Pharma Ltd Compounds
EP3257855B1 (en) * 2015-02-12 2020-04-22 Shanghai Dude Medical Science and Technology Co., Ltd. Method for preparing ibrutinib
MA41828A (en) * 2015-03-27 2018-01-30 Pharmacyclics Llc CO-CRYSTALS OF A TYROSINE KINASE INHIBITOR FROM BRUTON
CN106146511A (en) * 2015-04-03 2016-11-23 安润医药科技（苏州）有限公司 Pyrazolopyrimidine derivative, preparation method, pharmaceutical composition and purposes
WO2016154998A1 (en) * 2015-04-03 2016-10-06 安润医药科技（苏州）有限公司 Pyrazolopyrimidine derivative, manufacturing method, pharmaceutical composition, and use thereof
CN104844609B (en) * 2015-05-12 2016-07-13 杭州和正医药有限公司 The irreversible bruton's tyrosine kinase inhibitor of dibit point
CN105777759B (en) * 2016-04-29 2018-01-26 杭州和正医药有限公司 A kind of bruton's tyrosine kinase inhibitor
CN108431007B (en) 2015-09-16 2022-06-07 洛克索肿瘤学股份有限公司 Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer
CN114591242B (en) 2015-12-16 2025-01-07 洛克索肿瘤学股份有限公司 Compounds useful as kinase inhibitors
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
HRP20210844T1 (en) * 2015-12-23 2021-07-09 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
CN106928231B (en) * 2015-12-31 2021-06-01 合肥中科普瑞昇生物医药科技有限公司 Novel EGFR wild type and mutant kinase inhibitors
MX384569B (en) 2016-01-15 2025-03-14 Pfizer DOPAMINE D3 LIGANDS 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE
WO2017133630A1 (en) * 2016-02-05 2017-08-10 北京盛诺基医药科技有限公司 Inhibitor of bruton's tyrosine kinase
EP3433246B1 (en) 2016-03-24 2022-05-04 Mission Therapeutics Limited 1-cyano-pyrrolidine derivatives as dbu inhibitors
CN106146518A (en) * 2016-06-30 2016-11-23 苏州爱玛特生物科技有限公司 A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof
WO2018002958A1 (en) 2016-06-30 2018-01-04 Sun Pharma Advanced Research Company Limited Novel hydrazide containing compounds as btk inhibitors
BR112019003504A2 (en) 2016-08-24 2019-05-21 Arqule, Inc. amino pyrrolopyrimidinone compounds and methods of use thereof
GB201616511D0 (en) 2016-09-29 2016-11-16 Mission Therapeutics Limited Novel compounds
GB201616627D0 (en) 2016-09-30 2016-11-16 Mission Therapeutics Limited Novel compounds
ES3006132T3 (en) * 2016-11-15 2025-03-17 Hangzhou Healzen Therapeutics Co Ltd Selective bruton's tyrosine kinase inhibitor and use thereof
CN109369654A (en) * 2018-11-20 2019-02-22 山东大学 1,3-Disubstituted-4-aminopyrazolopyrimidine compounds and preparation method and application thereof
WO2020263822A1 (en) * 2019-06-25 2020-12-30 San Diego State University Foundation Selective btk irreversible inhibitors
WO2021038540A1 (en) 2019-08-31 2021-03-04 Sun Pharma Advanced Research Company Limited Cycloalkylidene carboxylic acids and derivatives as btk inhibitors
JP7011638B2 (en) * 2019-12-16 2022-02-10 アークル インコーポレイテッド Tetrahydropyranylamino-pyrrolopyrimidinone and how to use it
CN113214265B (en) * 2020-01-21 2023-07-07 江苏先声药业有限公司 Pyrimidine five-membered ring compound
RU2747991C1 (en) * 2020-02-18 2021-05-18 Аркьюл, Инк. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of its use
JP2023518006A (en) * 2020-03-12 2023-04-27 フォチョン・バイオサイエンシーズ・リミテッド Compounds as kinase inhibitors
WO2022140246A1 (en) 2020-12-21 2022-06-30 Hangzhou Jijing Pharmaceutical Technology Limited Methods and compounds for targeted autophagy
CN114761410B (en) * 2021-04-06 2023-08-25 广州必贝特医药股份有限公司 Pyrrolopyrimidinone compounds and application thereof
WO2022213932A1 (en) * 2021-04-06 2022-10-13 广州必贝特医药股份有限公司 Pyrrolopyrimidinone compound and application thereof
CN115894500B (en) * 2022-11-02 2024-05-28 中国药科大学 Compound serving as BTK kinase inhibitor and preparation method and application thereof
CN118702697A (en) * 2023-03-18 2024-09-27 山东新时代药业有限公司 Benzoyl pyrrolopyrimidine derivatives and their use and preparation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2201840B1 (en) 2006-09-22 2011-11-02 Pharmacyclics, Inc. Inhibitors of Bruton's Tyrosine Kinase
US8987233B2 (en) 2006-11-03 2015-03-24 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
EP2560007A1 (en) 2007-03-28 2013-02-20 Pharmacyclics, Inc. Identification of bruton's tyrosine kinase inhibitors
NZ603525A (en) 2008-06-27 2015-02-27 Celgene Avilomics Res Inc Pyrimidine based compound and uses thereof
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
US8426428B2 (en) 2008-12-05 2013-04-23 Principia Biopharma, Inc. EGFR kinase knockdown via electrophilically enhanced inhibitors
US7741330B1 (en) 2009-10-12 2010-06-22 Pharmacyclics, Inc. Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
MX342405B (en) 2010-06-03 2016-09-28 Pharmacyclics Inc The use of inhibitors of bruton's tyrosine kinase (btk).
BR112013029508B1 (en) 2011-05-17 2022-05-03 Principia Biopharma, Inc. Compound, pharmaceutical composition, and use of said compound
ES2604191T3 (en) 2011-05-17 2017-03-03 Principia Biopharma Inc. Tyrosine Kinase Inhibitors
CA2841080A1 (en) 2011-07-13 2013-01-17 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Also Published As

Publication number Publication date
WO2014188173A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL240903B (en) Tetrahydropyrrolothiazine compounds
GB201309085D0 (en) Compounds
GB201310542D0 (en) Compounds
GB201302927D0 (en) Compounds
GB201311951D0 (en) Compounds
GB201309508D0 (en) Compounds
GB201317619D0 (en) Compounds
GB201319363D0 (en) Compounds
GB201320636D0 (en) Compounds
GB201311953D0 (en) Compounds
IL240904B (en) Azetidinyloxyphenylpyrrolidine compounds
GB201312901D0 (en) Compounds
EP2948457A4 (en) Compounds
GB201306794D0 (en) Compounds
IL240964A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201318461D0 (en) Compounds
GB201316014D0 (en) Compounds
GB201310460D0 (en) Compounds
GB201322855D0 (en) Compounds
GB201322028D0 (en) Compounds
GB201321553D0 (en) Compounds
GB201321554D0 (en) Compounds
GB201321283D0 (en) Compounds
GB201318323D0 (en) Compounds
GB201318143D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)